NCT05570994 2026-01-08
177Lu-HTK03170 in mCRPC With PSMA Positive Disease
British Columbia Cancer Agency
Phase 1/2 Enrolling by invitation
Clinical Trials
1 trialsEnrolling by invitation × Interventional × Metastatic Castration-resistant Prostate Cancer × Clear all